FDA Adverse Event Injury Summary report: N

ULTRAGUIDECTR

MDR report key: 17998348 · Received October 24, 2023

Report

Report Number
3013479847-2023-00008
Event Type
Injury
Date Received
October 24, 2023
Date of Event
September 1, 2023
Report Date
October 24, 2023
Manufacturer
SONEX HEALTH
Product Code
LXH
UDI-DI
00860002094700
PMA / PMN Number
K192873
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
VT, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS NOT RETURNED FOR ANALYSIS. ADDITIONALLY, THE LOT NUMBER WAS NOT REPORTED AND THEREFORE A REVIEW OF DEVICE HISTORY RECORDS COULD NOT BE PERFORMED. INFECTION IS REFERENCED IN THE ULTRAGUIDECTR INSTRUCTIONS FOR USE AS A POSSIBLE COMPLICATION. NO DEVICE MALFUNCTION WAS REPORTED.

Description of Event or Problem · 0

THE PATIENT HAD RIGHT-HAND AND LEFT-HAND CARPAL TUNNEL RELEASE USING ULTRAGUIDECTR WITH ULTRASOUND GUIDANCE. 11 DAYS AFTER SURGERY, PATIENT HAD ONSET OF INCREASING PAIN, STIFFNESS AND SWELLING WITH CLEAR FLUID DISCHARGE FROM RIGHT HAND INCISION SITE ONLY. PATIENT STATES THE LEFT HAND IS HEALING WELL WITHOUT ISSUES. THE PATIENT PRESENTED TO EMERGENCY DEPARTMENT FOR EVALUATION CONCERNING FLEXOR TENOSYNOVITIS/INFECTIOUS COMPLICATION OF RIGHT HAND. NO FEVER OR CHILLS. THE PATIENT HAD SUPERFICIAL ABRASION TO RIGHT WRIST 3-4 DAYS PRIOR BY MOVING WOOD. PATIENT REPORTED THAT RIGHT HAND WAS HEALING WELL BUT WOKE UP WITH THE NEW SYMPTOMS: ACUTE ONSET OF SIGNIFICANT PAIN TO RIGHT WRIST AND PALMAR ASPECT OF RIGHT HAND ALONG FOURTH OR FIFTH FLEXOR SHEATH. THE POSSIBILITY THAT THE INFECTIOUS COMPLICATION RESULTED FROM FIREWOOD ABRASION WAS NOTED. OPEN AND DEBRIDEMENT OF RIGHT HAND. ANTIBIOTICS WERE GIVEN. DIAGNOSIS WAS INFECTIOUS FLEXOR TENOSYNOVITIS. NO DEVICE MALFUNCTION WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
922651 ULTRAGUIDECTR CARPAL TUNNEL RELEASE SYSTEM LXH SONEX HEALTH 600112-001 00860002094700

Patients

Seq Age Sex Outcome Treatment
1 65 YR Male Required Intervention